Lobular in situ neoplasia and columnar cell lesions: diagnosis in breast core biopsies and implications for management

References

• Foote F. W., Stewart F. W. Lobular carcinoma in situ: a rare form of mammary carcinoma. Am J Pathol 1941; 17: 491–9
   PubMedGoogle Scholar
• Ewing J. Neoplastic Diseases: A Textbook on Tumors. WB Saunders, Philadelphia 1919
   Google Scholar
• Haagensen C. D., Lane N., Lattes R., et al. Lobular neoplasia (so‐called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737–69
   PubMed Web of Science ®Google Scholar
• Page D. L., Kidd T. E Jr., Dupont W. D., et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991; 22: 1232–9
   PubMed Web of Science ®Google Scholar
• Simpson P. T., Gale T., Fulford L. G., et al. The diagnosis and management of pre‐invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res 2003; 5: 258–62
   PubMed Web of Science ®Google Scholar
• Chuba P. J., Hamre M. R., Yap J., et al. Bilateral risk for subsequent breast cancer after lobular carcinoma‐in‐situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 2005; 23: 5534–41
   PubMed Web of Science ®Google Scholar
• Page D. L., Dupont W. D., Rogers L. W., et al. Atypical hyperplastic lesions of the female breast. A long‐term follow‐up study. Cancer 1985; 55: 2698–708
   PubMed Web of Science ®Google Scholar
• Non‐operative Diagnosis Subgroup of the National Coordinating Group for Breast Screening Pathology. Guidelines for Non‐operative Diagnostic Procedures and Reporting in Breast Cancer Screening. NHS Cancer Screening Programmes, Sheffield 2001, NHS BSP Publication No 50
   Google Scholar
• Page D. L., Anderson T. J., Rogers L. W. Carcinoma in situ (CIS). Diagnostic Histopathology of the Breast, D. L Page, T. J Anderson. Churchill Livingstone, New York 1987; 157–92
   Google Scholar
• Haagensen C. D. Diseases of the breast. WB Saunders, Philadelphia 1971
   Google Scholar
• Sneige N., Wang J., Baker B. A., et al. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal‐lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 2002; 15: 1044–50
   PubMed Web of Science ®Google Scholar
• Wheeler J. E., Enterline H. T., Roseman J. M., et al. Lobular carcinoma in situ of the breast. Long‐term followup. Cancer 1974; 34: 554–63
   PubMed Web of Science ®Google Scholar
• Eusebi V., Magalhaes F., Azzopardi J. G. Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Hum Pathol 1992; 23: 655–62
   PubMed Web of Science ®Google Scholar
• Reis‐Filho J. S., Simpson P. T., Jones C., et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol 2005; 207: 1–13
   PubMed Web of Science ®Google Scholar
• Chen Y., Fitzgibbons P., Jacobs T., et al. Pleomorphic apocrine lobular carcinoma in situ (PALCIS): Phenotypic and genetic study of a distinct‐variant of lobular carcinoma in situ (LCIS). Lab Invest 2005; 85: 29A
   Web of Science ®Google Scholar
• Eusebi V., Magalhaes F., Azzopardi J. G. Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Hum Pathol 1992; 23: 655–62
   PubMed Web of Science ®Google Scholar
• Frolik D., Caduff R., Varga Z. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. Histopathology 2001; 39: 503–13
   PubMed Web of Science ®Google Scholar
• Maluf H. M. Differential diagnosis of solid carcinoma in situ. Semin Diagn Pathol 2004; 21: 25–31
   PubMed Web of Science ®Google Scholar
• Maluf H. M., Swanson P. E., Koerner F. C. Solid low‐grade in situ carcinoma of the breast: role of associated lesions and E‐cadherin in differential diagnosis. Am J Surg Pathol 2001; 25: 237–44
   PubMed Web of Science ®Google Scholar
• Jacobs T. W., Pliss N., Kouria G., et al. Carcinomas in situ of the breast with indeterminate features: role of E‐cadherin staining in categorization. Am J Surg Pathol 2001; 25: 229–36
   PubMed Web of Science ®Google Scholar
• De Leeuw W. J., Berx G., Vos C. B., et al. Simultaneous loss of E‐cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997; 183: 404–11
   PubMed Web of Science ®Google Scholar
• Vos C. B., Cleton‐Jansen A. M., Berx G., et al. E‐cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997; 76: 1131–3
   PubMed Web of Science ®Google Scholar
• Berx G., Cleton‐Jansen A. M., Strumane K., et al. E‐cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996; 13: 1919–25
   PubMed Web of Science ®Google Scholar
• Mastracci T. L., Tjan S., Bane A. L., et al. E‐cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 2005; 18: 741–51
   PubMed Web of Science ®Google Scholar
• Sarrio D., Perez‐Mies B., Hardisson D., et al. Cytoplasmic localization of p120ctn and E‐cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene 2004; 23: 3272–83
   PubMed Web of Science ®Google Scholar
• Bratthauer G. L., Moinfar F., Stamatakos M. D., et al. Combined E‐cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 2002; 33: 620–7
   PubMed Web of Science ®Google Scholar
• Bratthauer G. L., Miettinen M., Tavassoli F. A. Cytokeratin immunoreactivity in lobular intraepithelial neoplasia. J Histochem Cytochem 2003; 51: 1527–31
   PubMed Web of Science ®Google Scholar
• Turner N. C., Reis‐Filho J. S. Basal‐like breast cancer and the BRCA1 phenotype. Oncogene 2006; 25: 5846–53
   PubMed Web of Science ®Google Scholar
• Fulford L. G., Reis‐Filho J. S., Lakhani S. R. Lobular in situ neoplasia. Curr Diagn Pathol 2004; 10: 183–92
   Google Scholar
• Fraser J. L., Raza S., Chorny K., Connolly J. L., Schnitt S. J. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 1998; 22: 1521–7
   PubMed Web of Science ®Google Scholar
• McLaren B. K., Gobbi H., Schuyler P. A., et al. Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies: a nested case‐control study. Am J Surg Pathol 2005; 29: 105–10
   PubMed Web of Science ®Google Scholar
• Azzopardi J. G. Problems in Breast Pathology. WB Saunders, Philadelphia 1978; 193–202
   Google Scholar
• Oyama T., Maluf H., Koerner F. Atypical cystic lobules: an early stage in the formation of low‐grade ductal carcinoma in situ. Virchows Arch 1999; 435: 413–21
   PubMed Web of Science ®Google Scholar
• Arpino G., Laucirica R., Elledge R. M. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 2005; 143: 446–57
   PubMed Web of Science ®Google Scholar
• Tavassoli F. A., Hoefler H., Rosai J., . Intraductal proliferative lesions. Pathology and Genetics: Tumours of the Breast and Female Genital Organs, F. A Tavassoli, P Devilee, et al. IARC Press, Lyon 2003; 63–73
   Google Scholar
• Schnitt S. J., Vincent‐Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol 2003; 10: 113–24
   PubMed Web of Science ®Google Scholar
• Simpson P. T., Gale T., Reis‐Filho J. S., et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 2005; 29: 734–46
   PubMed Web of Science ®Google Scholar
• Fraser J. L. R. S., Chorny K., Connolly J. L., Schnitt S. J. Immunophenotype of columnar alteration with prominent apical snouts and secretions (CAPSS). Lab Invest 2000; 80: 21A
   Google Scholar
• Shoker B. S., Jarvis C., Clarke R. B., et al. Abnormal regulation of the oestrogen receptor in benign breast lesions. J Clin Pathol 2000; 53: 778–83
   PubMed Web of Science ®Google Scholar
• Tremblay G., Deschenes J., Alpert L., Quenneville L. A. Overexpression of estrogen receptors in columnar cell change and in unfolding breast lobules. Breast J 2005; 11: 326–32
   PubMed Web of Science ®Google Scholar
• Rosen P. P. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol 1999; 23: 1561
   PubMed Web of Science ®Google Scholar
• Sahoo S., Recant W. M. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast. Breast J 2005; 11: 140–2
   PubMed Web of Science ®Google Scholar
• Cleton‐Jansen A. M. E‐cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?. Breast Cancer Res 2002; 4: 5–8
   PubMed Web of Science ®Google Scholar
• van Wezel T., Lombaerts M., van Roon E. H., et al. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q. Breast Cancer Res 2005; 7: R998–1004
   PubMed Web of Science ®Google Scholar
• Rakha E. A., Green A. R., Powe D. G., et al. Chromosome 16 tumor‐suppressor genes in breast cancer. Genes Chromosomes Cancer 2006; 45: 527–35
   PubMed Web of Science ®Google Scholar
• Roylance R., Droufakou S., Gorman P., et al. The role of E‐cadherin in low‐grade ductal breast tumourigenesis. J Pathol 2003; 200: 53–8
   PubMed Web of Science ®Google Scholar
• Brooks‐Wilson A. R., Kaurah P., Suriano G., et al. Germline E‐cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004; 41: 508–17
   PubMed Web of Science ®Google Scholar
• Sarrio D., Moreno‐Bueno G., Hardisson D., et al. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E‐cadherin and catenin expression and microsatellite instability. Int J Cancer 2003; 106: 208–15
   PubMed Web of Science ®Google Scholar
• Droufakou S., Deshmane V., Roylance R., et al. Multiple ways of silencing E‐cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 2001; 92: 404–8
   PubMed Web of Science ®Google Scholar
• Brooks‐Wilson A. R., Kaurah P., Suriano G., et al. Germline E‐cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004; 41: 508–17
   PubMed Web of Science ®Google Scholar
• Lu Y. J., Osin P., Lakhani S. R., et al. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998; 58: 4721–7
   PubMed Web of Science ®Google Scholar
• Buerger H., Simon R., Schafer K. L., et al. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 2000; 53: 118–21
   PubMedGoogle Scholar
• Etzell J. E., Devries S., Chew K., et al. Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol 2001; 32: 292–6
   PubMed Web of Science ®Google Scholar
• Shelley Hwang E., Nyante S. J., Yi Chen Y., et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004; 100: 2562–72
   PubMed Web of Science ®Google Scholar
• Loo L. W., Grove D. I., Williams E. M., et al. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res 2004; 64: 8541–9
   PubMed Web of Science ®Google Scholar
• Reis‐Filho J. S., Simpson P. T., Turner N. C., et al. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin Cancer Res 2006; 12: 6652–62
   PubMed Web of Science ®Google Scholar
• Morandi L., Marucci G., Foschini M. P., et al. Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast. Virchows Arch 2006; 449: 14–23
   PubMed Web of Science ®Google Scholar
• Moinfar F., Man Y. G., Bratthauer G. L., Ratschek M., Tavassoli F. A. Genetic abnormalities in mammary ductal intraepithelial neoplasia‐flat type (‘clinging ductal carcinoma in situ’): a simulator of normal mammary epithelium. Cancer 2000; 88: 2072–81
   PubMed Web of Science ®Google Scholar
• Simpson P. T., Gale T., Reis‐Filho J. S., et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 2005; 29: 734–46
   PubMed Web of Science ®Google Scholar
• Dabbs D. J., Carter G., Fudge M., Peng Y., Swalsky P., Finkelstein S. Molecular alterations in columnar cell lesions of the breast. Mod Pathol 2006; 19: 344–9
   PubMed Web of Science ®Google Scholar
• Page D. L., Schuyler P. A., Dupont W. D., et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003; 361: 125–9
   PubMed Web of Science ®Google Scholar
• Fisher E. R., Land S. R., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve‐year observations concerning lobular carcinoma in situ. Cancer 2004; 100: 238–44
   PubMed Web of Science ®Google Scholar
• Maluf H., Koerner F. Lobular carcinoma in situ and infiltrating ductal carcinoma: frequent presence of DCIS as a precursor lesion. Int J Surg Pathol 2001; 9: 127–31
   PubMed Web of Science ®Google Scholar
• Ho B. C., Tan P. H. Flat epithelial atypia: concepts and controversies of an intraductal lesion of the breast. Pathology 2005; 37: 105–111
   PubMed Web of Science ®Google Scholar
• Eusebi V., Feudale E., Foschini M. P., et al. Long‐term follow‐up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11: 223–35
   PubMed Web of Science ®Google Scholar
• Bijker N., Peterse J. L., Duchateau L., et al. Risk factors for recurrence and metastasis after breast‐conserving therapy for ductal carcinoma‐in‐situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001; 19: 2263–71
   PubMed Web of Science ®Google Scholar
• de Mascarel I., MacGrogan G., Picot V., Douggaz A., Mathoulin‐Pélissier S. Results of a long term follow‐up study of 115 patients with flat epithelial atypia. Lab Invest 2006; 86: 25A
   Web of Science ®Google Scholar
• Schnitt S. J. The diagnosis and management of pre‐invasive breast disease: flat epithelial atypia ‐ classification, pathologic features and clinical significance. 2003; 5: 263–268, Breast Cancer Res
   Google Scholar
• Middleton L. P., Grant S., Stephens T., et al. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?. Mod Pathol 2003; 16: 120–9
   PubMed Web of Science ®Google Scholar
• Jacobs T. W., Connolly J. L., Schnitt S. J. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?. Am J Surg Pathol 2002; 26: 1095–110
   PubMed Web of Science ®Google Scholar
• Crisi G. M., Mandavilli S., Cronin E., et al. Invasive mammary carcinoma after immediate and short‐term follow‐up for lobular neoplasia on core biopsy. Am J Surg Pathol 2003; 27: 325–33
   PubMed Web of Science ®Google Scholar
• O'Driscoll D., Britton P., Bobrow L., et al. Lobular carcinoma in situ on core biopsy‐what is the clinical significance?. Clin Radiol 2001; 56: 216–20
   PubMed Web of Science ®Google Scholar
• Shin S. J., Rosen P. P. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med 2002; 126: 697–701
   PubMed Web of Science ®Google Scholar
• Renshaw A. A., Derhagopian R. P., Martinez P., et al. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Am J Clin Pathol 2006; 126: 310–3
   PubMed Web of Science ®Google Scholar
• Renshaw A. A., Cartagena N., Schenkman R. H., et al. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow‐up biopsies. Am J Clin Pathol 2001; 116: 92–6
   PubMed Web of Science ®Google Scholar
• Bauer V. P., Ditkoff B. A., Schnabel F., et al. The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J 2003; 9: 4–9
   PubMedGoogle Scholar
• Dmytrasz K., Tartter P. I., Mizrachy H., et al. The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J 2003; 9: 10–2
   PubMedGoogle Scholar
• Elsheikh T. M., Silverman J. F. Follow‐up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 2005; 29: 534–43
   PubMed Web of Science ®Google Scholar
• Mahoney M. C., Robinson‐Smith T. M., Shaughnessy E. A. Lobular neoplasia at 11‐gauge vacuum‐assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow‐up. AJR Am J Roentgenol 2006; 187: 949–54
   PubMed Web of Science ®Google Scholar
• Liberman L., Sama M., Susnik B., et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol 1999; 173: 291–9
   PubMed Web of Science ®Google Scholar
• Lee A. H., Denley H. E., Pinder S. E., et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology 2003; 42: 331–6
   PubMed Web of Science ®Google Scholar
• Margenthaler J. A., Duke D., Monsees B. S., Barton P. T., Clark C., Dietz J. R. Correlation between core biopsy and excisional biopsy in breast high‐risk lesions. Am J Surg 2006; 192: 534–7
   PubMed Web of Science ®Google Scholar
• Arpino G., Allred D. C., Mohsin S. K., Weiss H. L., Conrow D., Elledge R. M. Lobular neoplasia on core‐needle biopsy ‐ clinical significance. Cancer 2004; 101: 242–50
   PubMed Web of Science ®Google Scholar
• Lim C. N., Ho B. C., Bay B. H., Yip G., Tan P. H. Nuclear morphometry in columnar cell lesions of the breast: is it useful?. J Clin Pathol. 2006, Epub ahead of print
   Google Scholar
• Brogi E., Tan L. K. Findings at excisional biopsy (EBX) performed after identification of columnar cell change (CCC) of ductal epithelium in breast core biopsy (CBX). Mod Pathol 2002; 5: 9A–30
   Google Scholar
• Harigopal M. Y. D., Hoda S. A., DeLellis R. A., Vazquez M. F. Columnar cell alteration diagnosed on mammotome core biopsy for indeterminate microcalcifications: Results of subsequent mammograms and surgical excision. Mod Pathol 2002; 15: 6
   PubMed Web of Science ®Google Scholar
• Nasser S., Fan M. J. Does atypical columnar cell hyperplasia on breast core biopsy warrant follow‐up excision?. Mod Pathol 2003; 16: 2A
   Web of Science ®Google Scholar
• Kunju L. P., Kleer C. G. Significance of flat epithelial atypia (FEA) on mammotome core needle biopsy: Should it be excised?. Lab Invest 2006; 86: 32A
   PubMed Web of Science ®Google Scholar
• Lubelsky S. M., Bane A. L., Shin V., Kulkarni S., O'Malley F. P. Columnar cell lesions and flat epithelial atypia: Incidence and significance in a mammographically screened population. Lab Invest 2005; 85: 41A
   Web of Science ®Google Scholar
• Bai H., Sung C. J., Wu Q., et al. Flat epithelial atypia in breast needle core biopsies: A correlative followup study. Lab Invest 2005; 85: 25A
   Web of Science ®Google Scholar
• Xu C., Chung A., Giri D. Diagnosis of columnar cell change with atypia on breast core biopsy: Impact of inter‐observer variability, degree of atypia and the volume of lesional changes on surgical management. Lab Invest 2005; 85: 55A
   Web of Science ®Google Scholar